Woodcock: black boxes shouldn't be the 'new warnings section'

Share this article:
Responding to criticism of why it took 15 years to order a black box for fluoroquinolones, the FDA's Janet Woodcock said: “If we put every serious drug ADR in a black box, black boxes will just become the new warnings section, since most drugs have some serious ADRs associated with them.” 
Share this article:

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.